Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;100:2184-2190

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bauer, A.
Right arrow Articles by Schöls, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bauer, A.
Right arrow Articles by Schöls, W.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Electrophysiology
Right arrow Cardiovascular Pharmacology
Right arrow Animal models of human disease
Right arrow Arrythmias-basic studies
Right arrow Information technology

(Circulation. 1999;100:2184.)
© 1999 American Heart Association, Inc.


Basic Science Reports

Rate- and Site-Dependent Effects of Propafenone, Dofetilide, and the New IKs-Blocking Agent Chromanol 293b on Individual Muscle Layers of the Intact Canine Heart

Alexander Bauer, MD; Ruediger Becker, MD; Kirsten D. Freigang, MD; Julia C. Senges, MD; Frederik Voss, MD; Alexander Hansen, MD; Matthias Müller, MD; Hans Jochen Lang, PhD; Uwe Gerlach, PhD; Andreas Busch, PhD; Patricia Kraft, RN; Wolfgang Kübler, MD; Wolfgang Schöls, MD

From the Department of Cardiology, University of Heidelberg (A. Bauer, R.B., K.D.F., J.C.S., F.V., A.H., M.M., P.K., W.K., W.S.), and Hoechst Marion Roussel, Cardiovascular Pharmacology, Frankfurt (H.J.L., U.G., A. Busch), Germany.

Correspondence to Dr Alexander Bauer, Abteilung Innere Medizin III, Medizinische Universitätsklinik, Bergheimerstraße 58, 69115 Heidelberg, Germany. E-mail alexander_bauer{at}med.uni-heidelberg.de

Background—Recent in vitro studies have demonstrated regional differences in electrophysiological properties of individual left ventricular muscle layers. Controversy exists on the relevance of these findings for the situation in vivo. Thus, this study was designed to determine whether the in vivo canine heart exhibits regional differences in left ventricular refractoriness and in the susceptibility to sodium and potassium channel blockers.

Methods and Results—In 16 dogs, 36 needle electrodes (12 mm long, 4 bipolar electrodes, interelectrode distance 2.5 mm) were inserted into the left ventricular wall. By use of a computerized multiplexer-mapping system, the spread of activation in epicardial, endocardial, and midmyocardial muscle was reconstructed during ventricular pacing at 300- and 850-ms basic cycle length (BCL). Effective refractory periods (ERPs) were determined at baseline and after application of propafenone (2 mg/kg), dofetilide (30 µg/kg), or chromanol 293b (10 mg/kg) by the extrastimulus technique (BCL 300 and 850 ms). At baseline, activation patterns and ERPs were uniform in all muscle layers. Propafenone homogeneously decreased conduction velocity and moderately prolonged ERPs without any regional differences. Dofetilide and chromanol 293b did not affect the spread of activation. Dofetilide exhibited reverse use-dependent effects on ERP, still preserving transmural homogeneity of refractoriness. Chromanol 293b led to a regionally uniform but more pronounced increase in local ERPs at faster than at slower pacing rates.

Conclusions—At the heart rates applied, the in vivo canine heart does not exhibit regional differences in electrophysiological properties. Given the homogeneity of antiarrhythmic drug effects, induction of local gradients of refractoriness is obviously not a common mechanism of proarrhythmia in normal hearts.


Key Words: antiarrhythmia agents • arrhythmia • electrophysiology • mapping




This article has been cited by other articles:


Home page
CirculationHome page
M. J. Janse, E. A. Sosunov, R. Coronel, T. Opthof, E. P. Anyukhovsky, J. M.T. de Bakker, A. N. Plotnikov, I. N. Shlapakova, P. Danilo Jr, J. G.P. Tijssen, et al.
Repolarization Gradients in the Canine Left Ventricle Before and After Induction of Short-Term Cardiac Memory
Circulation, September 20, 2005; 112(12): 1711 - 1718.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. E Conrath, R. Wilders, R. Coronel, J. M.T de Bakker, P. Taggart, J. R de Groot, and T. Opthof
Intercellular coupling through gap junctions masks M cells in the human heart
Cardiovasc Res, May 1, 2004; 62(2): 407 - 414.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. G.A. Volders, M. Stengl, J. M. van Opstal, U. Gerlach, R. L.H.M.G. Spatjens, J. D.M. Beekman, K. R. Sipido, and M. A. Vos
Probing the Contribution of IKs to Canine Ventricular Repolarization: Key Role for {beta}-Adrenergic Receptor Stimulation
Circulation, June 3, 2003; 107(21): 2753 - 2760.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. J. Lynch Jr., J. J. Salata, A. A. Wallace, G. L. Stump, D. B. Gilberto, H. Jahansouz, N. J. Liverton, H. G. Selnick, and D. A. Claremon
Antiarrhythmic Efficacy of Combined IKs and beta -Adrenergic Receptor Blockade
J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 283 - 289.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Antzelevitch
Transmural dispersion of repolarization and the T wave
Cardiovasc Res, June 1, 2001; 50(3): 426 - 431.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Taggart, P. M.I Sutton, T. Opthof, R. Coronel, R. Trimlett, W. Pugsley, and P. Kallis
Transmural repolarisation in the left ventricle in humans during normoxia and ischaemia
Cardiovasc Res, June 1, 2001; 50(3): 454 - 462.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
S. K. Doshi and B. N. Singh
Reviews: Pure Class III Antiarrhythmic Drugs: Focus on Dofetilide
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(4): 237 - 247.
[PDF]


Home page
EuropaceHome page
P. Dorian and D. Newman
Rate dependence of the effect of antiarrhythmic drugs delaying cardiac repolarization: an overview
Europace, January 1, 2000; 2(4): 277 - 285.
[Abstract] [PDF]


Home page
CirculationHome page
D. O. Kozhevnikov, K. Yamamoto, D. Robotis, M. Restivo, and N. El-Sherif
Electrophysiological Mechanism of Enhanced Susceptibility of Hypertrophied Heart to Acquired Torsade de Pointes Arrhythmias: Tridimensional Mapping of Activation and Recovery Patterns
Circulation, March 5, 2002; 105(9): 1128 - 1134.
[Abstract] [Full Text] [PDF]